首页 > 最新文献

Ugeskrift for laeger最新文献

英文 中文
[Autoimmune progesterone dermatitis]. 自身免疫性黄体酮性皮炎。
Q4 Medicine Pub Date : 2025-11-17 DOI: 10.61409/V06250533
Johanna Larsson, Kristian Fredløv Mose, Anette Bygum

Autoimmune progesterone dermatitis (APD) is a rare, cyclic condition triggered by sensitisation to exogenous and/or endogenous progesterone. In this case report, we present a 44-year-old woman with presumed primary sensitisation from an intrauterine device, followed by cross-reactivity to endogenous progesterone. The patient experienced significant symptom relief following treatment with omalizumab. In conclusion, APD is diagnostically challenging due to its variable presentation, but treatment with omalizumab has shown promising results.

自身免疫性黄体酮皮炎(APD)是一种罕见的周期性疾病,由外源性和/或内源性黄体酮致敏引起。在本病例报告中,我们报告了一位44岁的女性,她被推测为宫内节育器致敏,随后对内源性黄体酮产生交叉反应。患者在奥玛珠单抗治疗后症状明显缓解。总之,APD的诊断具有挑战性,因为其表现多变,但使用omalizumab治疗已显示出令人鼓舞的结果。
{"title":"[Autoimmune progesterone dermatitis].","authors":"Johanna Larsson, Kristian Fredløv Mose, Anette Bygum","doi":"10.61409/V06250533","DOIUrl":"https://doi.org/10.61409/V06250533","url":null,"abstract":"<p><p>Autoimmune progesterone dermatitis (APD) is a rare, cyclic condition triggered by sensitisation to exogenous and/or endogenous progesterone. In this case report, we present a 44-year-old woman with presumed primary sensitisation from an intrauterine device, followed by cross-reactivity to endogenous progesterone. The patient experienced significant symptom relief following treatment with omalizumab. In conclusion, APD is diagnostically challenging due to its variable presentation, but treatment with omalizumab has shown promising results.</p>","PeriodicalId":23428,"journal":{"name":"Ugeskrift for laeger","volume":"187 47","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-11-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145640365","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Transthyretin amyloid cardiomyopathy]. 转甲状腺素淀粉样心肌病。
Q4 Medicine Pub Date : 2025-11-17 DOI: 10.61409/V04250323
Sie Kronborg Fensman, Ale Hussein Jaber Mejren, Tor Skibsted Clemmensen, Steen Hvitfeldt Poulsen

Transthyretin amyloidosis (ATTR-CM) is an infiltrative cardiomyopathy caused by the deposition of amyloid fibrils, leading to heart failure, arrhythmias, and increased mortality. ATTR-CM prevalence is rising. The first disease-modifying drugs have been approved and implemented in Denmark. Additional treatments slowing ATTR-CM progression are pending introduction into clinical practice. Treatments halting or even reversing progression are currently being investigated in clinical trials. The new therapies will significantly improve ATTR-CM-associated morbidity and mortality, as argued in this review.

甲状腺素转淀粉样变性(atr - cm)是一种由淀粉样原纤维沉积引起的浸润性心肌病,可导致心力衰竭、心律失常和死亡率增加。atr - cm患病率正在上升。首个疾病修饰药物已在丹麦获得批准和实施。其他减缓atr - cm进展的治疗方法正在等待引入临床实践。目前正在临床试验中研究阻止甚至逆转病情进展的治疗方法。新疗法将显著改善atr - cm相关的发病率和死亡率。
{"title":"[Transthyretin amyloid cardiomyopathy].","authors":"Sie Kronborg Fensman, Ale Hussein Jaber Mejren, Tor Skibsted Clemmensen, Steen Hvitfeldt Poulsen","doi":"10.61409/V04250323","DOIUrl":"https://doi.org/10.61409/V04250323","url":null,"abstract":"<p><p>Transthyretin amyloidosis (ATTR-CM) is an infiltrative cardiomyopathy caused by the deposition of amyloid fibrils, leading to heart failure, arrhythmias, and increased mortality. ATTR-CM prevalence is rising. The first disease-modifying drugs have been approved and implemented in Denmark. Additional treatments slowing ATTR-CM progression are pending introduction into clinical practice. Treatments halting or even reversing progression are currently being investigated in clinical trials. The new therapies will significantly improve ATTR-CM-associated morbidity and mortality, as argued in this review.</p>","PeriodicalId":23428,"journal":{"name":"Ugeskrift for laeger","volume":"187 47","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-11-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145640331","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Metachronous colon cancer after successful treatment of mismatch repair-deficient metastatic colorectal cancer]. [错配修复缺陷转移性结直肠癌成功治疗后的异时性结肠癌]。
Q4 Medicine Pub Date : 2025-11-17 DOI: 10.61409/V05250368
Line Hansen, Michael Bødker Lauritzen, Christian Thomsen, Inga Makieva, Malene Lundsgaard, Lykke Grubach, Laurids Ø Poulsen

Colorectal cancer (CRC) is considered to be a heterogeneous disease with different molecular subtypes based on the expression status of mismatch repair (MMR) e.g. It is well known that tumours with mismatch repair deficiency (dMMR) are associated with better prognosis, as well as a more effective response to immunotherapy. In this case report, a patient is diagnosed with three new dMMR tumors in the colon 3,5 years after successful treatment with immunotherapy for metastatic CRC. Until now, retreatment with immunotherapy has not been described in the literature, and this case report describes the advantages and disadvantages from this perspective.

基于错配修复(MMR)的表达状态,结直肠癌(CRC)被认为是一种具有不同分子亚型的异质性疾病,例如,众所周知,具有错配修复缺陷(dMMR)的肿瘤预后更好,对免疫治疗的反应也更有效。在本病例报告中,一名患者在接受转移性结直肠癌的免疫治疗成功后,在结肠中被诊断出三个新的dMMR肿瘤。到目前为止,文献中还没有描述免疫治疗的再治疗,本病例报告从这个角度描述了它的优点和缺点。
{"title":"[Metachronous colon cancer after successful treatment of mismatch repair-deficient metastatic colorectal cancer].","authors":"Line Hansen, Michael Bødker Lauritzen, Christian Thomsen, Inga Makieva, Malene Lundsgaard, Lykke Grubach, Laurids Ø Poulsen","doi":"10.61409/V05250368","DOIUrl":"10.61409/V05250368","url":null,"abstract":"<p><p>Colorectal cancer (CRC) is considered to be a heterogeneous disease with different molecular subtypes based on the expression status of mismatch repair (MMR) e.g. It is well known that tumours with mismatch repair deficiency (dMMR) are associated with better prognosis, as well as a more effective response to immunotherapy. In this case report, a patient is diagnosed with three new dMMR tumors in the colon 3,5 years after successful treatment with immunotherapy for metastatic CRC. Until now, retreatment with immunotherapy has not been described in the literature, and this case report describes the advantages and disadvantages from this perspective.</p>","PeriodicalId":23428,"journal":{"name":"Ugeskrift for laeger","volume":"187 47","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-11-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145640334","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Vaccination in pregnancy]. [怀孕期间接种疫苗]。
Q4 Medicine Pub Date : 2025-11-10 DOI: 10.61409/V03250236
Ellen Moseholm, Nina Weis

Vaccination during pregnancy is an effective and safe way to protect both the pregnant individual and the child from serious infections as presented in this review. Influenza, COVID-19, and pertussis vaccines are routinely recommended and provide proven benefits for both mother and newborn. While inactivated and recombinant vaccines are safe to use, live-attenuated vaccines are contraindicated during pregnancy. Despite their importance, pregnant individuals are often excluded from clinical vaccine studies, highlighting the need for more research on maternal antibody transfer and optimal vaccination strategies in pregnancy.

在怀孕期间接种疫苗是保护孕妇和儿童免受严重感染的有效和安全的方法。流感、COVID-19和百日咳疫苗是常规推荐疫苗,并已证实对母亲和新生儿都有益处。虽然使用灭活疫苗和重组疫苗是安全的,但在怀孕期间禁用减毒活疫苗。尽管它们很重要,但孕妇往往被排除在临床疫苗研究之外,这突出表明需要更多地研究母体抗体转移和妊娠期最佳疫苗接种策略。
{"title":"[Vaccination in pregnancy].","authors":"Ellen Moseholm, Nina Weis","doi":"10.61409/V03250236","DOIUrl":"https://doi.org/10.61409/V03250236","url":null,"abstract":"<p><p>Vaccination during pregnancy is an effective and safe way to protect both the pregnant individual and the child from serious infections as presented in this review. Influenza, COVID-19, and pertussis vaccines are routinely recommended and provide proven benefits for both mother and newborn. While inactivated and recombinant vaccines are safe to use, live-attenuated vaccines are contraindicated during pregnancy. Despite their importance, pregnant individuals are often excluded from clinical vaccine studies, highlighting the need for more research on maternal antibody transfer and optimal vaccination strategies in pregnancy.</p>","PeriodicalId":23428,"journal":{"name":"Ugeskrift for laeger","volume":"187 46","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145565347","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Vaccination for travelling]. [旅行疫苗接种]。
Q4 Medicine Pub Date : 2025-11-10 DOI: 10.61409/V04250247
Carsten Schade Larsen, Peter Henrik Andersen, Lars Peter Nielsen, Marie Helleberg

Travel activity is high among Danes and pretravel advice is important to prevent infections. This review concludes that recommendations for vaccines are based on the incidence and consequences of travel-related infections. Further, advice should be individualised based on the destination, duration and type of travel, expected future travel, comorbidity, whether the traveler belongs to a risk group (elderly, pregnant women and children), and knowledge of any current outbreaks of infectious diseases. Recently, new vaccines against dengue fever and chikungunya fever have been marketed and several are under development.

丹麦人的旅游活跃度很高,旅行前的建议对预防感染很重要。本综述的结论是,对疫苗的建议是基于旅行相关感染的发生率和后果。此外,应根据目的地、旅行时间和类型、预期未来旅行、合并症、旅行者是否属于危险群体(老年人、孕妇和儿童)以及对当前任何传染病爆发的了解情况,提供个性化建议。最近,针对登革热和基孔肯雅热的新疫苗已经上市,有几种正在开发中。
{"title":"[Vaccination for travelling].","authors":"Carsten Schade Larsen, Peter Henrik Andersen, Lars Peter Nielsen, Marie Helleberg","doi":"10.61409/V04250247","DOIUrl":"https://doi.org/10.61409/V04250247","url":null,"abstract":"<p><p>Travel activity is high among Danes and pretravel advice is important to prevent infections. This review concludes that recommendations for vaccines are based on the incidence and consequences of travel-related infections. Further, advice should be individualised based on the destination, duration and type of travel, expected future travel, comorbidity, whether the traveler belongs to a risk group (elderly, pregnant women and children), and knowledge of any current outbreaks of infectious diseases. Recently, new vaccines against dengue fever and chikungunya fever have been marketed and several are under development.</p>","PeriodicalId":23428,"journal":{"name":"Ugeskrift for laeger","volume":"187 46","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145565354","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Vaccination of older adults]. [老年人的疫苗接种]。
Q4 Medicine Pub Date : 2025-11-10 DOI: 10.61409/V04250252
Aksel Nathan Harbsmeier, Martin Schultz, Christina Ekenberg, Carsten Schade Larsen, Lotte Usinger, Zitta Barrella Harboe

This review presents vaccination as an effective measure in preventing hospitalisation and death in older adults. Older adults are at higher risk of severe infections due to several factors, including immunosenescence, multiple comorbidities and frailty. In Denmark, there is a free seasonal vaccination program against influenza and COVID-19 for individuals aged ≥ 65 years. Other relevant vaccines are available for this age group, including against pneumococcal disease, RSV and herpes zoster. Awareness of the benefits of vaccination in the elderly can help protect this vulnerable group from severe infections and their consequences.

这篇综述提出疫苗接种是预防老年人住院和死亡的有效措施。由于多种因素,包括免疫衰老、多种合并症和虚弱,老年人发生严重感染的风险更高。在丹麦,65岁以上的个人可免费接种流感和COVID-19季节性疫苗。其他相关疫苗适用于这一年龄组,包括肺炎球菌病、呼吸道合胞病毒和带状疱疹疫苗。认识到老年人接种疫苗的好处可以帮助保护这一弱势群体免受严重感染及其后果。
{"title":"[Vaccination of older adults].","authors":"Aksel Nathan Harbsmeier, Martin Schultz, Christina Ekenberg, Carsten Schade Larsen, Lotte Usinger, Zitta Barrella Harboe","doi":"10.61409/V04250252","DOIUrl":"https://doi.org/10.61409/V04250252","url":null,"abstract":"<p><p>This review presents vaccination as an effective measure in preventing hospitalisation and death in older adults. Older adults are at higher risk of severe infections due to several factors, including immunosenescence, multiple comorbidities and frailty. In Denmark, there is a free seasonal vaccination program against influenza and COVID-19 for individuals aged ≥ 65 years. Other relevant vaccines are available for this age group, including against pneumococcal disease, RSV and herpes zoster. Awareness of the benefits of vaccination in the elderly can help protect this vulnerable group from severe infections and their consequences.</p>","PeriodicalId":23428,"journal":{"name":"Ugeskrift for laeger","volume":"187 46","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145565467","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Vaccine contraindications, scepticism and acceptance]. [疫苗禁忌症,怀疑和接受]。
Q4 Medicine Pub Date : 2025-11-10 DOI: 10.61409/V03250197
Frederikke Dam Larsen, Zitta Barrella Harboe, Gitte Kronborg, Michael Dalager-Pedersen

The growing spread of myths and misinformation about vaccines has contributed to increased vaccine hesitancy and decreased vaccine acceptance worldwide. However, true contraindications and precautions to vaccination are rare. To ensure a high vaccine uptake, and thereby contributing to herd immunity and reducing illness, hospitalisation and mortality, it is essential to educate both healthcare professionals and the general population about the effectiveness and safety of vaccines as argued in this review. In Denmark, the use of electronic nudging has successfully contributed to increased vaccine uptake.

关于疫苗的谣言和错误信息日益传播,导致全世界对疫苗的犹豫增加,疫苗接受度下降。然而,真正的禁忌症和预防接种是罕见的。为了确保疫苗的高接种率,从而促进群体免疫,减少疾病、住院和死亡率,正如本综述所述,必须对卫生保健专业人员和普通人群进行疫苗有效性和安全性的教育。在丹麦,电子助推的使用成功地促进了疫苗的吸收。
{"title":"[Vaccine contraindications, scepticism and acceptance].","authors":"Frederikke Dam Larsen, Zitta Barrella Harboe, Gitte Kronborg, Michael Dalager-Pedersen","doi":"10.61409/V03250197","DOIUrl":"https://doi.org/10.61409/V03250197","url":null,"abstract":"<p><p>The growing spread of myths and misinformation about vaccines has contributed to increased vaccine hesitancy and decreased vaccine acceptance worldwide. However, true contraindications and precautions to vaccination are rare. To ensure a high vaccine uptake, and thereby contributing to herd immunity and reducing illness, hospitalisation and mortality, it is essential to educate both healthcare professionals and the general population about the effectiveness and safety of vaccines as argued in this review. In Denmark, the use of electronic nudging has successfully contributed to increased vaccine uptake.</p>","PeriodicalId":23428,"journal":{"name":"Ugeskrift for laeger","volume":"187 46","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145565431","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vaccination igennem hele livet.
Q4 Medicine Pub Date : 2025-11-10 DOI: 10.61409/V10250847
Tyra Grove Krause
{"title":"Vaccination igennem hele livet.","authors":"Tyra Grove Krause","doi":"10.61409/V10250847","DOIUrl":"https://doi.org/10.61409/V10250847","url":null,"abstract":"","PeriodicalId":23428,"journal":{"name":"Ugeskrift for laeger","volume":"187 46","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145565438","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Vaccination of individuals undergoing immunosuppressive therapy]. [接受免疫抑制治疗的个体接种疫苗]。
Q4 Medicine Pub Date : 2025-11-10 DOI: 10.61409/V04250249
Zitta Barrella Harboe, Peter Henrik Andersen, Peter Asdahl, Trine Bertelsen, Stephan Bramow, Henrik Jørn Ditzel, Christina Ekenberg, Marie Helleberg, Jens Ulrik Jensen, Mette Julsgaard, Carsten Schade Larsen, Hans Henrik Lawaetz Schultz, Daria Podlekareva, Susanne Dam Nielsen, Karin Skov, Anne Troldborg, Søren Jensen-Fangel

Protecting individuals undergoing immunosuppressive therapy through vaccination remains a clinical challenge due to the heterogeneity of underlying conditions and immunosuppressive treatments. These patients are at increased risk of severe infections, yet vaccination uptake remains suboptimal. Although vaccine responses may be reduced, this review finds vaccination to be generally safe, except for live attenuated vaccines, which should be avoided due to the risk of severe disease. A structured, multidisciplinary approach to vaccination may enhance uptake and improve protection in this vulnerable patient group.

由于潜在疾病和免疫抑制治疗的异质性,通过接种疫苗来保护接受免疫抑制治疗的个体仍然是一项临床挑战。这些患者严重感染的风险增加,但疫苗接种仍然不理想。虽然疫苗反应可能会降低,但本综述发现,除了减毒活疫苗外,疫苗接种总体上是安全的,由于存在严重疾病的风险,应避免接种。一种结构化的、多学科的疫苗接种方法可以增强这一脆弱患者群体的吸收和保护。
{"title":"[Vaccination of individuals undergoing immunosuppressive therapy].","authors":"Zitta Barrella Harboe, Peter Henrik Andersen, Peter Asdahl, Trine Bertelsen, Stephan Bramow, Henrik Jørn Ditzel, Christina Ekenberg, Marie Helleberg, Jens Ulrik Jensen, Mette Julsgaard, Carsten Schade Larsen, Hans Henrik Lawaetz Schultz, Daria Podlekareva, Susanne Dam Nielsen, Karin Skov, Anne Troldborg, Søren Jensen-Fangel","doi":"10.61409/V04250249","DOIUrl":"https://doi.org/10.61409/V04250249","url":null,"abstract":"<p><p>Protecting individuals undergoing immunosuppressive therapy through vaccination remains a clinical challenge due to the heterogeneity of underlying conditions and immunosuppressive treatments. These patients are at increased risk of severe infections, yet vaccination uptake remains suboptimal. Although vaccine responses may be reduced, this review finds vaccination to be generally safe, except for live attenuated vaccines, which should be avoided due to the risk of severe disease. A structured, multidisciplinary approach to vaccination may enhance uptake and improve protection in this vulnerable patient group.</p>","PeriodicalId":23428,"journal":{"name":"Ugeskrift for laeger","volume":"187 46","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145565449","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Vaccination in solid organ transplantation]. [实体器官移植中的疫苗接种]。
Q4 Medicine Pub Date : 2025-11-10 DOI: 10.61409/V03250242
Sebastian Rask Hamm, Christina Ekenberg, Hans Henrik Lawaetz Schultz, Lykke Larsen, Karin Skov, Marie Helleberg, Søren Jensen-Fangel, Zitta Barrella Harboe, Carsten Schade Larsen, Susanne Dam Nielsen

Solid organ transplant (SOT) recipients receive maintenance immunosuppressive therapy and are at risk of infections and severe infection-related disease. Despite weaker immunological responses to vaccines in SOT recipients compared to controls, this review finds that vaccination has been associated with a lower risk of severe disease, and vaccination before transplantation is recommended in international and Danish guidelines. A national programme for vaccination of SOT candidates has been implemented in Denmark, and vaccination coverage is high for patients participating in the programme.

实体器官移植(SOT)受者接受维护性免疫抑制治疗,有感染和严重感染相关疾病的风险。尽管与对照组相比,SOT受者对疫苗的免疫反应较弱,但本综述发现,接种疫苗与严重疾病的风险较低有关,国际和丹麦指南建议在移植前接种疫苗。丹麦已经实施了一项为SOT候选人接种疫苗的国家规划,参与该规划的患者的疫苗接种覆盖率很高。
{"title":"[Vaccination in solid organ transplantation].","authors":"Sebastian Rask Hamm, Christina Ekenberg, Hans Henrik Lawaetz Schultz, Lykke Larsen, Karin Skov, Marie Helleberg, Søren Jensen-Fangel, Zitta Barrella Harboe, Carsten Schade Larsen, Susanne Dam Nielsen","doi":"10.61409/V03250242","DOIUrl":"https://doi.org/10.61409/V03250242","url":null,"abstract":"<p><p>Solid organ transplant (SOT) recipients receive maintenance immunosuppressive therapy and are at risk of infections and severe infection-related disease. Despite weaker immunological responses to vaccines in SOT recipients compared to controls, this review finds that vaccination has been associated with a lower risk of severe disease, and vaccination before transplantation is recommended in international and Danish guidelines. A national programme for vaccination of SOT candidates has been implemented in Denmark, and vaccination coverage is high for patients participating in the programme.</p>","PeriodicalId":23428,"journal":{"name":"Ugeskrift for laeger","volume":"187 46","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145565462","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Ugeskrift for laeger
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1